Kala Bio Inc.

-0.13 (-1.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)22.45M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.83 Million
Adjusted EPS-$3.46
See more estimates
10-Day MA$9.97
50-Day MA$12.82
200-Day MA$14.92
See more pivots

Kala Bio Inc. Stock, NASDAQ:KALA

1167 Massachusetts Avenue, Suite 120, Arlington, Massachusetts 02476
United States of America
Phone: +1.781.996.5252
Number of Employees: 34


KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.